Dr. Albensi is Chair and Professor in the Department of Pharmaceutical sciences, Co-Director of B.R.A.I.N. (Brain Research and Integrated Nutrition Center) College of Pharmacy, Nova Southeastern University, Ft. Lauderdale, FL.

He is Editor-in-Chief of Molecular Neurobiology and is best known for his work with factors involved in aging, cognition, and Alzheimer’s disease (AD), such as nuclear factor kappa B (NF-kB), a mediator of inflammation but also a required molecule for memory. He has been ranked in the top 1% worldwide by Expertscape.com for his number of publications from 2010-2020 in 7 areas including Alzheimer Disease (0.48%), neurocognitive disorders (0.76%), tauopathies (0.98%), dementia (0.85%), NF-kappa B (0.42%), memory (68%) & energy metabolism (0.68%).

He has a Ph.D. in Neuroscience from the University of Utah’s Medical School, was a Postdoctoral Fellow at Georgetown University in Washington, DC, where he developed MRI methods for investigating head trauma and cognition. He worked as a Postdoctoral Scholar with Dr. Mark Mattson at the Sanders-Brown Center on Aging – University of Kentucky where he was the first to show NF-kB is required for hippocampal synaptic plasticity in mammals. Other appointments have included the Cleveland Clinic, NPS Pharmaceuticals, Pfizer, Case Western Reserve University, St. Boniface Hospital Research Ctr., and the University of Manitoba.

His recent work has largely focused on mitochondrial dysfunction in AD. The Albensi lab has shown very early deficits and sex-based differences in mitochondrial function before the appearance of plaques and tangles, the classic hallmarks of AD.